ROYAL BANK OF CANADA - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 352 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.4%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$4,290,000
-74.2%
24,825
-82.9%
0.00%
-72.7%
Q4 2014$16,657,000
+20.7%
144,928
+64.0%
0.01%
+22.2%
Q3 2014$13,805,000
-17.6%
88,360
-34.9%
0.01%
-18.2%
Q2 2014$16,753,000
+19.4%
135,817
+0.3%
0.01%
+10.0%
Q1 2014$14,027,000
-2.0%
135,391
-14.9%
0.01%0.0%
Q4 2013$14,311,000
+0.8%
159,111
-25.1%
0.01%
-9.1%
Q3 2013$14,203,000
+14.7%
212,365
+13.4%
0.01%
+10.0%
Q2 2013$12,387,000187,2590.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 467,943$30,954,00011.01%
TANG CAPITAL MANAGEMENT LLC 300,000$19,845,0007.82%
OAK RIDGE INVESTMENTS LLC 1,382,895$91,478,0002.87%
SECTOR GAMMA AS 147,001$9,724,0002.84%
Credo Capital Management, LLC 38,869$2,571,0001.98%
Cardinal Capital Management 48,226$3,190,0001.89%
ZEVENBERGEN CAPITAL INVESTMENTS LLC 626,800$41,463,0001.68%
HERNDON CAPITAL MANAGEMENT LLC 1,284,472$84,967,823,0001.27%
CATAPULT CAPITAL MANAGEMENT LLC 45,000$2,977,0001.24%
Pier Capital, LLC 108,556$7,181,0001.10%
View complete list of SALIX PHARMACEUTICALS INC shareholders